Analysts expect Cytokinetics Inc to report revenue of 42.14 M for Q3 26, against a range of 38.35 M to 45.94 M. The most recent reported quarter, Q2 26, came in at 28.62 M, a 54.7% beat against the 18.50 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 463,000.00 | 16.93 M | 1.60 M | 66.77 M | 1.94 M | 17.75 M | 19.36 M | 28.62 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.20 M | 1.99 M | 3.92 M | 2.31 M | 6.42 M | 7.80 M | 9.50 M | 20.09 M | 45.94 M | 63.93 M | 60.68 M | 93.67 M | 138.20 M | 312.86 M | 92.11 M | 198.70 M | ||||||||||
| Low Estimate | 1.10 M | 1.68 M | 3.24 M | 2.01 M | 5.28 M | 6.91 M | 8.43 M | 16.91 M | 38.35 M | 59.72 M | 52.66 M | 77.00 M | 120.47 M | 269.37 M | 83.15 M | 174.96 M | ||||||||||
| Consensus Estimate | 1.15 M | 1.83 M | 3.58 M | 2.16 M | 5.85 M | 7.36 M | 8.96 M | 18.50 M | 42.14 M | 61.83 M | 56.67 M | 85.33 M | 129.34 M | 291.12 M | 87.63 M | 186.83 M |
Analysts expect Cytokinetics Inc to report earnings per share of -1.51 for Q3 26, against a range of -1.59 to -1.43. The most recent reported quarter, Q2 26, came in at -1.50, a 5.1% beat against the -1.58 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.36 | -1.26 | -1.36 | -1.12 | -2.55 | -1.50 | -1.67 | -1.50 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.26 | -1.13 | -1.34 | -1.36 | -1.39 | -1.42 | -1.45 | -1.47 | -1.43 | -1.42 | -1.27 | -1.17 | -1.41 | -1.03 | -0.47 | -0.36 | ||||||||||
| Low Estimate | -1.34 | -1.33 | -1.48 | -1.62 | -1.67 | -1.60 | -1.71 | -1.69 | -1.59 | -1.62 | -1.37 | -1.39 | -1.59 | -1.25 | -0.57 | -0.42 | ||||||||||
| Consensus Estimate | -1.30 | -1.23 | -1.41 | -1.49 | -1.53 | -1.51 | -1.58 | -1.58 | -1.51 | -1.52 | -1.32 | -1.28 | -1.50 | -1.14 | -0.52 | -0.39 |
Pull Wall Street consensus for Cytokinetics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CYTK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CYTK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CYTK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();